We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets open in 2 hours

Doximity, Inc. (DOCS)

NYSE - NYSE Delayed Price. Currency in USD
Visitors trend2W10W9M
24.42-0.22 (-0.89%)
At close: 04:00PM EST
24.41 -0.01 (-0.04%)
Pre-Market: 07:01AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Performance Outlook
Previous Close24.64
Open24.54
Bid24.00 x 900
Ask24.42 x 1100
Day's Range24.14 - 24.71
52 Week Range19.71 - 40.12
Volume1,809,793
Avg. Volume2,153,153
Market Cap4.54B
Beta (5Y Monthly)1.04
PE Ratio (TTM)42.10
EPS (TTM)0.58
Earnings DateFeb 08, 2024 - Feb 12, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.27
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
52% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for DOCS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Doximity, Inc.
    DOCS: Lowering target price to $20.00DOXIMITY INC-CLASS A has an Investment Rating of SELL; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • InvestorPlace

    Top 3 Telehealth Stocks to Invest in for a Future of Virtual Care

    Telehealth stocks were all the rage during the pandemic, with many expecting the valuations of these companies to soar due to people staying home and practicing social distancing. However, as the old normal returned, some investors cast doubt over the long-term viability of telehealth stocks. The truth is this: The pandemic was a black swan event and a catalyst that sent the stock prices of telehealth stock soaring, but it didn’t change the long-term secular trends of the industries in which the

  • Simply Wall St.

    Some Investors May Be Worried About Doximity's (NYSE:DOCS) Returns On Capital

    If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...

  • Insider Monkey

    Doximity, Inc. (NYSE:DOCS) Q2 2024 Earnings Call Transcript

    Doximity, Inc. (NYSE:DOCS) Q2 2024 Earnings Call Transcript November 9, 2023 Doximity, Inc. beats earnings expectations. Reported EPS is $0.22, expectations were $0.18. Operator: Good afternoon. My name is Krista and I’ll be your conference operator today. At this time, I would like to welcome everyone to the Doximity’s Fiscal Second Quarter 2024 Earnings Call. […]

  • Barrons.com

    These Stocks Moved the Most Today: Plug Power, Trade Desk, Illumina, Doximity, Groupon, Hologic, and More

    Plug Power raises 'substantial doubt about its ability to continue as a going concern' and the stock plunges, Trade Desk falls sharply after its outlook for the fourth quarter is shy of Wall Street estimates, and Illumina slumps on weak guidance.

  • StockStory

    Doximity (DOCS) Shares Skyrocket, What You Need To Know

    Shares of healthcare professional network Doximity (NYSE:DOCS) jumped 29% in the morning session after the company reported a classic "beat and raise" quarter that investors love. Third quarter results beat Wall Street's expectations for revenue and handily beat expectations for Adjusted EBITDA and EPS. Additionally, it was good to see Doximity's optimistic revenue and adjusted EBITDA guidance for the next quarter, which exceeded analysts' expectations. Lastly, revenue and adjusted EBITDA guidan

  • Barrons.com

    Doximity Stock Rallies. Guidance Boost ‘Just What the Doctor Ordered.’

    The online platform for medical professionals also reported fiscal second-quarter adjusted earnings that beat analysts' estimates.

  • Zacks

    Doximity (DOCS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

    Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

  • StockStory

    Doximity (NYSE:DOCS) Delivers Strong Q2 Numbers, Stock Jumps 26.6%

    Healthcare professional network Doximity (NYSE:DOCS) reported Q2 FY2024 results beating Wall Street analysts' expectations, with revenue up 11.2% year on year to $113.6 million. On top of that, next quarter's revenue guidance ($127.5 million at the midpoint) was surprisingly good and 3.6% above what analysts were expecting. Turning to EPS, Doximity made a GAAP profit of $0.15 per share, improving from its profit of $0.12 per share in the same quarter last year.

  • Business Wire

    Doximity Announces Fiscal 2024 Second Quarter Financial Results

    SAN FRANCISCO, November 09, 2023--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2024 second quarter ended September 30, 2023.

  • StockStory

    Doximity (DOCS) Reports Earnings Tomorrow. What To Expect

    Healthcare professional network Doximity (NYSE:DOCS) will be reporting results tomorrow after market hours. Here's what to look for.